// App-Quantinova.ai

P354 : REAL-WORLD ANALYSIS OF THE RISKS OF THROMBOTIC AND BLEEDING EVENTS IN PATIENTS RECEIVING PEGYLATED ASPARAGINASE FOR TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Benjamin Mautner

Principal Investigators

  • Joseph Mort

  • Eric Pierce

  • Farid Ghamsari

  • Samantha Dibenedetto

  • Emily Morse

  • Leah Wells

  • Amy Morris

  • Cecily Allen

  • Imari Patel

  • Darren D'Souza

  • Clayton Jackson

  • Matthew Perciavalle

  • Bradley Yelvington

  • Ryan Miller

  • Karin Abernathy

  • Katherine Walsh

  • Heather Wolfe

  • Susan Locke

  • Daniel Reed

  • Vu Duong

  • Bhagirathbhai Dholaria

  • Thomas LeBlanc

  • Rory Shallis

  • Michael Keng

  • Bethany Horton

  • Firas El Chaer

Medical Centers

  • Hematology and Oncology,Wake Forest Baptist Medical Comprehensive Cancer Center,Winston-Salem,Stati Uniti

  • Hematology and Oncology,Duke Cancer Institute,Durham,Verenigde S

  • Hematology Oncology, University of Virginia, Charlottesville, VA

  • Hematology and Oncology,University of Virginia,Charlottesville,États-unis

  • Hematology and Oncology,University of Maryland Medical Center,Baltimore,United States

  • Hematology and Oncology,Vanderbilt University Medical Center

  • Public Health Sciences, Division of Translational Research and Applied Statistics,University of Virginia,Charlottesville,États-unis

  • Public Health Sciences, Division of Translational Research and Applied Statistics,University of Virginia,Charlottesville,États-unis

  • Public Health Sciences, Division of Translational Research and Applied Statistics,University of Virginia,Charlottesville,États-unis

  • Hematology and Oncology,Vanderbilt University Medical Center,Nashville,Vereinigte Staaten

  • Hematology and Oncology,Duke Cancer Institute,Durham,Verenigde S

  • Hematology and Oncology,Yale University,New Haven,United States

  • Hematology and Oncology,Duke Cancer Institute,Durham,Verenigde S

  • Hematology and Oncology,Wake Forest Baptist Medical Comprehensive Cancer Center,Winston-Salem,Stati Uniti

  • Hematology and Oncology,Duke University,Durham,United States

  • Hematology and Oncology,University of Maryland Medical C

  • Hematology and Oncology,Duke Cancer Institute,Durham,Verenigde S

  • Hematology and Oncology,Vanderbilt University Medical Center,Nashville,Vereinigte Staaten

  • Hematology and Oncology,Wake Forest Baptist Medical Comprehensive Cancer Center,Winston-Salem,Stati Uniti

  • Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN

  • Hematology and Oncology,Vanderbilt University Medical Center,Nashville,Vereinigte Staaten

  • Hematology and Oncology,University of Maryland Medical Center,Baltimore,United States

  • Hematology and Oncology,Duke Cancer Institute,Durham,Verenigde S

  • Hematology and O

  • Hematology and Oncology,University of Virginia,Charlottesville,États-unis

  • Hematology and Oncology,University of Virginia,Charlottesville,Estados Unidos

  • Hematology and Oncology,Wake Forest Baptist Medical Comprehensive Cancer Cen

  • Hematology and Oncology,University of Maryland Medical Center,Baltimore,United States

  • Hematology and Oncology,University of Maryland Medical Center,Baltimore,United States

  • Hematology

Locations

  • South Africa

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Asparaginase

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved